Monograph Details
|
|
Gastrointestinal Tract
> Colorectal disorders
|
|
PENTASA |
| Manufacturer |
|
Shire US, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Salicylate. |
| Generic Name |
|
Mesalamine 250mg, 500mg; controlled-rel caps. |
| Indications |
|
Mildly to moderately active ulcerative colitis. |
| Children |
|
Not recommended. |
| Adults |
|
1g four times daily for up to 8 weeks. |
| Precautions |
|
Sulfasalazine or aspirin allergy. Renal or hepatic dysfunction. Pregnancy (Cat.B). Nursing mothers. |
| Adverse Reactions |
|
GI upset, headache, abdominal pain, dyspepsia, rash; acute intolerance syndrome (rare, discontinue if occurs). |
| How Supplied |
Caps 250mg—240
500mg—120 |
|
|
|
|
